NCT07083687 2025-07-24Lorlatinib in ROS1+ NSCLC With Brain MetastasisHunan Cancer HospitalPhase 2 Not yet recruiting21 enrolled
NCT06690541 2024-11-15COMLORLAPeking University Cancer Hospital & InstituteNot yet recruiting100 enrolled